- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 15.69M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $14.82M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $620.9M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $621.68M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $114.28M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $148.32M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $245.42M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $243.98M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $937.85M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $926.71M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $661.76M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $661.87M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.38B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.35B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 16.97M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $23K |
| Capex | Q1 2025 · Mar 31, 2024 | $2.89M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $26.99M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.67 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.70 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $94.75M |
| Net Income | Q1 2025 · Mar 31, 2024 | $11.33M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $29.13M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $123.88M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $288.75M |
| Revenue | Q1 2025 · Mar 31, 2024 | $412.64M |